RichardAndrewMurphyMD

Assistant Professor, Medicine, Albert Einstein College of Medicine of Yeshiva Uni

Dr. Murphy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1520 San Pablo St
Suite 1000
Los Angeles, CA 90033
Phone+1 323-442-5100

Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 2005 - 2009
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2001 - 2005
Duke University School of MedicineClass of 2001

PubMed

Dolutegravir Resistance in African Programmatic Settings Among Patients With Failure of Dolutegravir-based ART.
Richard A Murphy, Pradeep H Bedesi, Nirmala Perumal, Bernadett I Gosnell, Timothy J Hatlen
Open Forum Infectious Diseases. 2024-07-01
What clinic closure reveals about care for drug-resistant TB: a qualitative study.
Thiloshini Govender, Jennifer J Furin, Alex Edwards, Selvan Pillay, Richard A Murphy
BMC Infectious Diseases. 2023-07-17
2 citations
Decentralized, Integrated Treatment of RR/MDR-TB and HIV Using a Bedaquiline-Based, Short-Course Regimen Is Effective and Associated With Improved HIV Disease Control.
Thiloshini Govender, Menal A Jham, Justin C Zhang, Selvan Pillay, Youngju Pak
Journal of Acquired Immune Deficiency Syndromes. 2023-04-15

FDA Adviser Recommends Full Approval of Pfizer’s Covid Drug PaxlovidMarch 17th, 2023
Advisors to the US Food and Drug Administration (FDA) Recommend Full Approval of Pfizer’s Covid Drug PaxlovidMarch 17th, 2023
FDA Advisors Recommend Full Approval of Pfizer Covid Treatment Paxlovid for Adults 50 and over and Other High-Risk PeopleMarch 16th, 2023
Join now to see all